Lebrikizumab for Moderate-to-Severe Atopic Dermatitis. Smith B, Engel P, Wu JJ. N Engl J Med 2023;388:2299.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Smith B, Engel P, Wu JJ. Lebrikizumab for Moderate-to-Severe Atopic Dermatitis. N Engl J Med 2023;388:2299.
PMID: 37314718